06Aug/13

Top Rated Report : Global Evolving Market for Biosimilar Opportunities … – SBWire (press release)

Top Rated Report : Global Evolving Market for Biosimilar Opportunities
SBWire (press release)
In terms of revenue, six of the top ten pharmaceutical therapies are biological products, which have been targeted by biosimilar developers: Abbvie’s Humira (adalimumab), Roche’s MabThera (rituximab), Herceptin (trastuzumab) and Avastin (bevacizumab),